(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FELIFERON

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

FELIFERON

ST13

US500000079427284

Class

5

Filing

79427284

Registration

8217550

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

07/21/2026

Trademark type

Combined

Nice classes

5

Filing date

06/04/2025

Registration date

04/21/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/21/2026

Last transaction

07/21/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

98

Owner location

RU

Examiner

SOUDERS, MICHAEL J

Law office

M60

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the word FELIFERON in a stylized font.

Holders and representatives

Holders

Obshchestvo s ogranichennoi otvetstvennostyu "BIOF
Obshchestvo s ogranichennoi otvetstvennostyu "BIOFERON"

Representatives

Burton S. Ehrlich Ladas & Parry LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Vaccines; medicines for the treatment of gastrointestinal diseases for veterinary purposes; biological preparations for the treatment of gastrointestinalacute respiratory and other diseases of viral or mixed infectious etiology in cats for veterinary purposes; vitamin preparations; chemical preparations for veterinary purposesnamely for the treatment of gastrointestinalacute respiratory and other diseases of viral or mixed infectious etiology in cats; bactericides; veterinary preparations for treatment of intestinal bacteria; pharmaceutical preparations for the treatment of gastrointestinalacute respiratory and other diseases of viral or mixed infectious etiology ; pharmaceutical preparations for animal skincare; antivirals

Publications

History of USPTO decisions and trademark events.

23 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/21/2026

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

05/07/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/21/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

04/21/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/03/2026

PUBO

PUBLISHED FOR OPPOSITION

03/03/2026

GPNX

NOTIFICATION PROCESSED BY IB

02/26/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/25/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/11/2026

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/10/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/03/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/02/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/02/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/02/2026

RFNT

REFUSAL PROCESSED BY IB

12/25/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/06/2025

RFRR

REFUSAL PROCESSED BY MPU

12/06/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/25/2025

CNRT

NON-FINAL ACTION WRITTEN

10/24/2025

DOCK

ASSIGNED TO EXAMINER

10/23/2025

MAFR

APPLICATION FILING RECEIPT MAILED

07/15/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/15/2025

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

07/03/2025

Continuous trademark protection

Get notified about every new filing that threatens FELIFERON or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.